Evoke Pharma Inc
NASDAQ:EVOK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evoke Pharma Inc
NASDAQ:EVOK
|
US |
|
Antilles Gold Ltd
ASX:AAU
|
AU |
|
Croma Security Solutions Group PLC
LSE:CSSG
|
UK |
|
F
|
Figene Capital SA
WSE:FIG
|
PL |
|
Avrupa Minerals Ltd
XTSX:AVU
|
CA |
|
Springfield Properties PLC
F:9MZ
|
UK |
|
L
|
Lowe's Companies Inc
XMUN:LWE
|
US |
|
F
|
Fremont Gold Ltd
OTC:FRERF
|
CA |
|
G
|
Greenvolt Energias Renovaveis SA
ELI:GVOLT
|
PT |
|
A
|
Avino Silver & Gold Mines Ltd
AMEX:ASM
|
CA |
|
AAA Technologies Ltd
NSE:AAATECH
|
IN |
|
Unico Silver Ltd
ASX:USL
|
AU |
|
A Paradise Acquisition Corp
NASDAQ:APAD
|
HK |
|
Sarama Resources Ltd
XTSX:SWA
|
AU |
|
Netlinkz Ltd
ASX:NET
|
AU |
|
M
|
Mida Assets PCL
SET:MIDA
|
TH |
|
C
|
Cloud Village Inc
HKEX:9899
|
CN |
|
So-Young International Inc
NASDAQ:SY
|
CN |
|
Castellana Properties Socimi SA
MAD:YCPS
|
ES |
Bankruptcy Probability
Evoke Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Evoke Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Evoke Pharma Inc
NASDAQ:EVOK
|
25.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
670.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
376.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
249.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
247.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Evoke Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Evoke Pharma Inc has total debt of 5m USD. This includes both short-term (5m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
